Daiwa Securities Group Inc. Agios Pharmaceuticals, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 204 shares of AGIO stock, worth $8,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
204
Previous 204
-0.0%
Holding current value
$8,441
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AGIO
# of Institutions
236Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$239 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$235 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$201 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$149 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$96.3 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.27B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...